Skip to main content
Screener/Healthcare/Biotechnology

INVA — Innoviva, Inc.

NASDAQ
$22.97+0.17 (+0.75%)
Small CapUnder $50HealthcareHigh ROELow BetaLow P/EMost ProfitableUndervalued
$16.52
$25.14
$22.70
$23.09
EPS (TTM)$6.01
P/E Ratio3.82
Dividend Yield—
Market Cap$1.49B
Volume360K
Prev Close$22.80
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$98.0M$186.6M$2.2277.4%190.4%
Q4 '25$118.0M$164.2M$1.9464.1%139.1%
Q3 '25$107.8M$89.9M$1.0876.1%83.4%
Q2 '25$100.3M$63.7M$0.7789.4%63.5%
Q1 '25$88.6M-$46.6M$-0.7490.0%-52.6%
Q4 '24$91.8M$20.3M$0.2492.2%22.1%
Q3 '24$89.5M$1.2M$0.0288.8%1.4%
Q2 '24$103.4M-$34.7M$-0.5582.2%-33.6%
Get Your Daily Market Recap